The president of the AHA (American Heart Association), Professor Clyde W. Yancy of the Baylor University Medical Center in Dallas Texas Kührt, in addition to 9 other studies in the areas of cardiovascular disease and stroke, the identification of a biomarker in Marfan syndrome. Quote:
" ... because there is for this autosomal-dominant connective tissue disease, which also attracts the aorta affected, a mouse model. Both the model and the patient is now a biomarker for this hereditary disease found been, the TGF-β (transforming growth factor-β circulating). The marker is significantly increased when a Marfan syndrome is present and has a close correlation to the diameter of the aortic root. The scientists in therapy experiments in animals and patients Angiotensinblocker the losartan and beta-blockers, both combined, used and found that ... "all text content, and the 9 crowned further studies are available behind the following PDF file onlinejournalismus.org
(Source: onlinejournalismus.org)
0 comments:
Post a Comment